Profile
Matthias Baumann formerly worked at FOCUS Clinical Drug Development GmbH, as Managing Director & Chief Scientific Officer in 2010, F.
Hoffmann-La Roche Ltd., as Medical Officer in 2002, MOLOGEN AG, as Chief Medical Officer from 2017 to 2020, Roche Diagnostics GmbH, as Head-Clinical Research & Development Group in 1998, NOXXON Pharma AG, as Chief Medical Officer from 2011 to 2017, and TME Pharma NV, as Chief Medical Officer.
Dr. Baumann received his doctorate degree in 1984 from Friedrich-Alexander University of Erlangen-Nuremberg.
Former positions of Matthias Baumann
| Companies | Position | End |
|---|---|---|
| MOLOGEN AG | Chief Tech/Sci/R&D Officer | 2020-04-29 |
| TME PHARMA N.V. | Chief Tech/Sci/R&D Officer | 2017-04-29 |
NOXXON Pharma AG
 NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Chief Tech/Sci/R&D Officer | 2016-12-31 |
FOCUS Clinical Drug Development GmbH
 FOCUS Clinical Drug Development GmbH Miscellaneous Commercial ServicesCommercial Services FOCUS Clinical Drug Development GmbH provides drug and clinical research and development services. The company is based in Neuss, Germany. FOCUS Clinical Drug Development was acquired by Nuvisan GmbH on November 05, 2010. | Chief Executive Officer | 2009-12-31 |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 2001-12-31 |
Training of Matthias Baumann
| Friedrich-Alexander University of Erlangen-Nuremberg | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| MOLOGEN AG | Commercial Services |
| TME PHARMA N.V. | Health Technology |
| Private companies | 4 |
|---|---|
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Health Technology |
Roche Diagnostics GmbH
 Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the private company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Commercial Services |
NOXXON Pharma AG
NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Health Technology |
FOCUS Clinical Drug Development GmbH
FOCUS Clinical Drug Development GmbH Miscellaneous Commercial ServicesCommercial Services FOCUS Clinical Drug Development GmbH provides drug and clinical research and development services. The company is based in Neuss, Germany. FOCUS Clinical Drug Development was acquired by Nuvisan GmbH on November 05, 2010. | Commercial Services |
- Stock Market
- Insiders
- Matthias Baumann